Iatrogenic Macular Hemorrhage after Dexamethasone Implant Injection

Klin Monbl Augenheilkd 2024; 241(04): 498-499
DOI: 10.1055/a-2282-3278

Kasuistik

Iatrogene Makulablutung nach Injektion eines Dexamethason-Implantats

Anna Friesacher

¹Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

,

Sascha Mathias Jung

¹Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

,

¹Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

,

Christophe Valmaggia

¹Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

,

Margarita G. Todorova

¹Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

²Department of Ophthalmology, University of Zürich, Zürich, Switzerland

References
1 Casati S, Bruni E, Marchini G. Retinal and vitreous hemorrhage after traumatic impact of dexamethasone implant in a vitrectomized eye. Eur J Ophthalmol 2016; 26: e55-e57
2 Elliott MS, Montezuma SR. Retina Injury After Dexamethasone Injection Into a Vitrectomized Eye. J Vitreoretin Dis 2020; 4: 538-540
3 Meyer CH, Klein A, Alten F. et al. Release and velocity of micronized dexamethasone implants with an intravitreal drug delivery system: kinematic analysis with a high-speed camera. Retina 2012; 32: 2133-2140
4 Bastakis GG, Dimopoulos D, Stavrakakis A. et al. Long-term efficacy and duration of action of dexamethasone implant, in vitrectomised and non-vitrectomised eyes with persistent diabetic macular oedema. Eye (Lond) 2019; 33: 411-418